Walton M, Wagner J
Genes (Basel). 2024; 15(3).
PMID: 38540438
PMC: 10969836.
DOI: 10.3390/genes15030379.
Zahra R, Ahmad R, Asghar M, Ali A, Soghra K
Indian J Clin Biochem. 2012; 21(1):121-5.
PMID: 23105582
PMC: 3453752.
DOI: 10.1007/BF02913079.
Albani J
J Fluoresc. 2011; 21(3):1301-9.
PMID: 21318433
DOI: 10.1007/s10895-010-0813-z.
Karakitsos D, Karabinis A, Kotsiou A
Eur J Drug Metab Pharmacokinet. 2010; 34(3-4):143-6.
PMID: 20166429
DOI: 10.1007/BF03191164.
Alam M, Awal M, Subhan N, Mostofa M
J Health Popul Nutr. 2009; 27(1):20-30.
PMID: 19248645
PMC: 2761805.
DOI: 10.3329/jhpn.v27i1.3315.
The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers.
Walle U, Fagan T, Topmiller M, Conradi E, Walle T
Br J Clin Pharmacol. 1994; 37(1):21-5.
PMID: 8148214
PMC: 1364704.
DOI: 10.1111/j.1365-2125.1994.tb04233.x.
Increased plasma propranolol binding in myocardial infarction.
Routledge P, Stargel W, Wagner G, SHAND D
Br J Clin Pharmacol. 1980; 9(4):438-40.
PMID: 7378264
PMC: 1429969.
DOI: 10.1111/j.1365-2125.1980.tb01077.x.
Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.
Sager G, Hansteen V, Aakesson I, Jacobsen S
Br J Clin Pharmacol. 1981; 12(5):613-20.
PMID: 7332725
PMC: 1401961.
DOI: 10.1111/j.1365-2125.1981.tb01279.x.
Altered plasma protein binding of drugs in thyroid disease.
Feely J, Stevenson I, Crooks J
Clin Pharmacokinet. 1981; 6(4):298-305.
PMID: 7249488
DOI: 10.2165/00003088-198106040-00004.
beta-blocker plasma concentrations and inflammatory disease: clinical implications.
Schneider R, Bishop H
Clin Pharmacokinet. 1982; 7(4):281-4.
PMID: 7116736
DOI: 10.2165/00003088-198207040-00001.
Unaltered serum propranolol binding by meal-induced variations in fatty acids.
Naranjo C, Sellers E, Khouw V
Br J Clin Pharmacol. 1982; 13(4):575-6.
PMID: 7066174
PMC: 1402056.
DOI: 10.1111/j.1365-2125.1982.tb01425.x.
Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid).
Muller W, Stillbauer A
Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(2):170-3.
PMID: 6866130
DOI: 10.1007/BF00512392.
Influence of age on serum protein binding of propranolol.
Bendayan R, Pieper J, Stewart R, Caranasos G
Eur J Clin Pharmacol. 1984; 26(2):251-4.
PMID: 6723765
DOI: 10.1007/BF00630294.
Changes in blood chemistry in hypertensive patients during propranolol therapy.
Andreasen F, Jakobsen P, Kornerup H, Pedersen E, Pedersen O, Weeke J
Br J Clin Pharmacol. 1984; 17(3):265-71.
PMID: 6712860
PMC: 1463379.
DOI: 10.1111/j.1365-2125.1984.tb02341.x.
Potential applications of free drug level monitoring in cardiovascular therapy.
Woosley R, Siddoway L, Thompson K, Cerskus I, Roden D
Clin Pharmacokinet. 1984; 9 Suppl 1:79-83.
PMID: 6705429
DOI: 10.2165/00003088-198400091-00010.
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.
Goolkasian D, Slaughter R, Edwards D, Lalka D
Eur J Clin Pharmacol. 1983; 25(3):413-7.
PMID: 6628530
DOI: 10.1007/BF01037957.
Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.
Pike E, Kierulf P, Skuterud B, Bredesen J, Lunde P
Br J Clin Pharmacol. 1983; 16(3):233-9.
PMID: 6626414
PMC: 1427992.
DOI: 10.1111/j.1365-2125.1983.tb02155.x.
Disease-induced changes in the plasma binding of basic drugs.
Piafsky K
Clin Pharmacokinet. 1980; 5(3):246-62.
PMID: 6156048
DOI: 10.2165/00003088-198005030-00004.
Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.
Guentert T, Oie S, PAALZOW L, Frey B, Brandt R, Aarons L
Br J Clin Pharmacol. 1987; 23(5):569-77.
PMID: 3593626
PMC: 1386193.
DOI: 10.1111/j.1365-2125.1987.tb03093.x.
Gallopamil binding to human serum proteins.
Rutledge D, Pieper J
Eur J Clin Pharmacol. 1987; 33(4):375-80.
PMID: 3443143
DOI: 10.1007/BF00637633.
